Skip to main content
Steven Canfield, MD, Urology, Houston, TX

StevenECanfieldMD

Urology Houston, TX

Surgical Oncology

Professor and Chief, Division of Urology, McGovern Medical School

Dr. Canfield is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Canfield's full profile

Already have an account?

  • Office

    6410 Fannin St
    Houston, TX 77030
    Phone+1 832-325-7280
    Fax+1 713-704-6260

Summary

  • Dr. Steven Canfield is a urologist in Houston, TX affiliated with Memorial Hermann, Harris Health System, and M.D. Anderson Cancer Center. He received his medical degree from Thomas Jefferson University and has been in practice 21 years. He specializes in urologic oncology and is experienced in robotic surgery and focal therapy. He has more than 80 publications and over 500 citings.

Education & Training

  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterFellowship, Urologic Surgical Oncology, 2002 - 2005
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiResidency, Urology, 1998 - 2002
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiResidency, Surgery, 1996 - 1998
  • Sidney Kimmel Medical College at Thomas Jefferson University
    Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1996

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2004 - 2025
  • FL State Medical License
    FL State Medical License 2007 - 2013
  • NY State Medical License
    NY State Medical License 1998 - 2008
  • PA State Medical License
    PA State Medical License 2006 - 2006
  • American Board of Urology Urology

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Prostate Cancer Triplet Therapy Including Darolutamide May Be Less Cardiotoxic
    Prostate Cancer Triplet Therapy Including Darolutamide May Be Less CardiotoxicOctober 15th, 2024
  • Promaxo Announces Clinical Collaboration with Mount Sinai Health System and UTHealth Houston
    Promaxo Announces Clinical Collaboration with Mount Sinai Health System and UTHealth HoustonFebruary 16th, 2023
  • Positive Margins Post-Prostatectomy: Does Size Matter?
    Positive Margins Post-Prostatectomy: Does Size Matter?June 29th, 2022
  • Join now to see all